26-1201
Austin, TXFile 26-1201
The City of Austin is considering a legislative action to authorize an agreement with Avita Drugs, LLC for pharmacy services under the 340B Drug Pricing Program. This initiative, set to begin on April 1, 2026, and lasting initially for six months, aims to provide qualified residents access to certain outpatient drugs at reduced prices. The agreement may extend for up to four years, potentially generating an additional $10,527 in revenue for the Austin Public Health Operating Budget. This program primarily benefits uninsured and low-income patients by enabling access to essential medications, including preventive treatments for HIV. The legislation underscores the city's commitment to enhancing public health services and maximizing the benefits of federal resources for local communities.
Title: Authorize negotiation and execution of an agreement with Avita Drugs, LLC for pharmacy services for qualified residents to receive certain outpatient drugs at reduced prices under the 340B Drug Pricing Program for an initial six-month term beginning on April 1, 2026, through September 30, 2026, with up to four twelve-month extension options ending on September 30, 2030. Funding: This item is projected to result in additional revenue of $10,527 in the Operating Budget of Austin Public Health.